Surgeon performs rare arterial bypass
KUWAIT: In a pioneering medical achievement, Dr Ahmed Amir, Consultant Vascular Surgeon at Jaber Al-Ahmad Hospital, has successfully performed the first arterial bypass operation in Kuwait and the Arabian Gulf region using a biograft made from a bovine carotid artery (Artegraft). The procedure was conducted on a 60-year-old patient suffering from severe ischemia in the lower limbs due to chronic and complex arterial blockages. Dr Amir explained that the patient's condition involved advanced arterial calcification, which rendered catheter-based interventions ineffective, necessitating surgical bypass.
The bypass was performed from the femoral artery to the artery below the knee using the biologically engineered graft, which served as an alternative to synthetic grafts or autologous veins—both of which were unavailable in this case. The graft, derived from the bovine carotid artery, undergoes a biological treatment process to become a natural tissue suitable for blood flow and highly resistant to infections. Dr Amir noted that this advanced technique offers a promising solution for patients lacking viable vein options, particularly those with chronic conditions such as diabetes and kidney failure. The procedure marks a significant step forward in treating acute limb ischemia, providing hope to patients who previously had no effective treatment options when traditional methods failed.
He further highlighted that the same biograft material can also be used to create arteriovenous (AV) fistulas for dialysis patients with renal failure who lack suitable veins, offering a safe and reliable alternative for long-term treatment. Dr Amir expressed his gratitude to the Ministry of Health for its continued efforts to equip Kuwait's healthcare system with the latest international medical technologies. He emphasized that the role of medical professionals goes beyond patient care to include introducing and adopting cutting-edge innovations that enhance treatment outcomes and improve the overall quality of healthcare in the country.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Kuwait Times
6 hours ago
- Kuwait Times
Kuwait cuts prices on 544 medicines, weight loss drugs
KUWAIT: Kuwait has slashed prices on key weight-loss and diabetes medications starting Monday, cutting the cost of the injection 'Tirzepatide' (Mounjaro) by 30 percent following a ministerial decree issued in May. Alongside this, prices for the diabetes drug 'Wegovy' dropped 37.3 percent, and the obesity medication 'Saxenda' was reduced by 20.8 percent—major moves to ease costs for patients battling diabetes and obesity. In a wider effort to improve healthcare affordability, Kuwait's Ministry of Health announced on Monday that it has reduced and approved new prices for 544 medicines and pharmaceutical products, with discounts reaching up to 78.5 percent. The ministry said 144 of these medicines now carry prices among the lowest in the Gulf region. The price cuts cover essential drugs for a broad range of conditions, including cancer treatments, antibiotics, diabetes, blood pressure, cholesterol, asthma, and biologic therapies for chronic diseases like arthritis, skin disorders, and colon illnesses. These latest decisions are part of a national policy for continuous review and adjustment of drug prices to boost economic efficiency in healthcare and ensure treatments remain affordable for both citizens and residents. The ministry also said it will continue to monitor markets closely to regulate prices on essential medicines. Earlier this year, the ministry approved pricing adjustments on nearly 1,188 medicines and pharmaceutical products, underscoring a consistent, sustainable approach to healthcare cost management. This includes the May decree that initiated the Tirzepatide price cut, alongside other reductions made in March 2025 and July and May 2024. — KUNA
Arab Times
10 hours ago
- Arab Times
Affordable Healthcare Boost: 544 Medicines See Price Drop In Kuwait
11/08/2025 KUWAIT CITY, Aug 11: Kuwaiti Minister of Health Ahmad Al-Awadhi on Monday made fresh decisions cutting the prices of 544 drugs and medical products by up to 78.5 percent. The decisions included new quotations of 144 drugs and products to be sold at the lowest prices in the Gulf only out of the Ministry of Health's commitment to providing medicines at reasonable prices and attaining economic sustainability in the medical care sector, the ministry said in a press release. The latest price cuts embrace cancer drugs, antibiotics and medications of diabetes, hypertension, cholesterol, asthma, arthritis, and skin and colon diseases. The medicine price list reductions come in the context of a national policy and continued review of repricing drugs, promoting the economic efficiency of the health sector, and ensuring low medication costs for citizens and residents alike, the ministry added. (KUNA)
Kuwait News Agency
10 hours ago
- Kuwait News Agency
كونا : Kuwait slashes prices of 544 drugs, medical products to 78.5 pct
11/08/2025 LOC19:52 16:52 GMT KUWAIT, Aug 11 (KUNA) -- Kuwaiti Minister of Health Ahmad Al-Awadhi on Monday made fresh decisions cutting the prices of 544 drugs and medical products by up to 78.5 percent. The decisions included new quotations of 144 drugs and products to be sold at the lowest prices in the Gulf only out of the Ministry of Health's commitment to providing medicines at reasonable prices and attaining economic sustainability in the medical care sector, the ministry said in a press release. The latest price cuts embrace cancer drugs, antibiotics and medications of diabetes, hypertension, cholesterol, asthma, arthritis, and skin and colon diseases. The medicine pricelist reductions come in the context of a national policy and continued review of repricing drugs, promoting the economic efficiency of the health sector, and ensuring low medication costs for citizens and residents alike, the ministry added. (end)
